Psychotropic medication and the heart

Advances in Psychiatric Treatment

Volumn 9, Issue 6, 2003, Pages 414-423

  O'Brien, Patrick ^a   Oyebode, Femi ^b  

^a LEICESTERSHIRE PARTNERSHIP NHS TRUST   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIARRHYTHMIC AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; CLOZAPINE; DOSULEPIN; DOXEPIN; DROPERIDOL; ENCAINIDE; FLECAINIDE; FLUOXETINE; IMIPRAMINE; MONOAMINE OXIDASE INHIBITOR; MORACIZINE; NEUROLEPTIC AGENT; NORTRIPTYLINE; OLANZAPINE; PHENOTHIAZINE; PLACEBO; PSYCHOTROPIC AGENT; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SODIUM CHANNEL BLOCKING AGENT; THIORIDAZINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; ZIPRASIDONE;

BRADYCARDIA; BRUGADA SYNDROME; CARDIOMYOPATHY; CIGARETTE SMOKING; CLINICAL PRACTICE; CONTROLLED STUDY; DEPRESSION; DRUG MISUSE; DRUG SAFETY; DRUG USE; EXERCISE; HEART ARREST; HEART ARRHYTHMIA; HEART DISEASE; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; LONG QT SYNDROME; MEDICAL DECISION MAKING; MEDICAL LITERATURE; MYOCARDITIS; OBESITY; PATIENT CARE; PSYCHOSIS; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SINUS TACHYCARDIA; TORSADE DES POINTES;

EID: 0242719689     PISSN: 13555146     EISSN: None     Source Type: Journal    
DOI: 10.1192/apt.9.6.414     Document Type: Review

References (35)

1. Agelink, M. W., Majewski, T., Wurthmann, C., et al (2001) Effects of newer atypical antipsychotics on autonomic neurocardiac function: a comparison between amisulpride, olanzapine, sertindole, and clozapine. Journal of Clinical Psychopharmacology, 21, 8-13.
2. Alings, M. & Wilde, W. (1999) "Brugada syndrome": clinical data and suggested pathophysiological mechanism. Circulation, 99, 666-673.
3. Alvarez-Mena, S. C. & Frank M. J. (1973) Phenothiazine-induced T-wave abnormalities. Effects of overnight fasting. Journal of the American Medical Association, 224, 1730-1733.
4. Arima, M., Kanoh, T., Kawano, Y., et al (2002) Serum levels of eosinophil cationic protein in patients with eosinophilic myocarditis. International Journal of Cardiology, 84, 97-99.
5. Bednar, M. M., Harrigan, E. P., Anziano, R. J., et al (2001) The QT interval. Progress in Cardiovascular Diseases, 43, 1-45.
6. Bigger, J. T Jr., Breithardt, G., Camm, A. J., et al (1996) Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation, 93, 1043-1065.
7. Burrows, G. D., Vohra, J., Hunt, D., et al (1976) Cardiac effects of different tricyclic antidepressant drugs. British Journal of Psychiatry, 129, 335-341.
8. Cardiac Arrhythmia Suppression Trial II Investigators (1992) Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. New England Journal of Medicine, 327, 227-233.
9. Cohen, H., Loewenthal, U., Matar, M. A., et al (2001) Reversal of pathologic cardiac parameters after transition from clozapine to olanzapine treatment: a case report. Clinical Neuropharmacology, 24, 106-108.
10. Engstrom, J. W. & Aminoff, M. J. (1997) Evaluation and treatment of orthostatic hypotension. American Family Physician, 56, 1378-1384.
11. Glassman, A. H. (1998) Cardiovascular effects of antidepressant drugs: updated. Journal of Clinical Psychiatry, 59 (suppl. 15), 13-18.
12. Glassman, A. H., Bigger, J. T., Giardina, E. V., et al (1979) Clinical characteristics of imipramine-induced orthostatic hypotension. Lancet, i, 468-472.
13. Glassman, A. H., O'Connor, C. M., Califf, R. M., et al (2002) Sertraline treatment of major depression in patients with acute MI or unstable angina. Journal of the American Medical Association, 288, 701-709.
14. Gorman, J. M. & Sloan, R. P. (2000) Heart rate variability in depressive and anxiety disorders. American Heart Journal, 140, S77-S83.
15. Hatta, K., Takahashi, T., Nakamura, H., et al (1999) Hypokalemia and agitation in acute psychotic patients. Psychiatry Research, 86, 85-88.
16. Khan, I. A. (2002) Clinical and therapeutic aspects of congenital and acquired long QT syndrome. American Journal of Medicine, 112, 58-66.
17. Kilian, J. G., Kerr, K., Lawrence, C., et al (1999) Myocarditis and cardiomyopathy associated with clozapine. Lancet, 354, 1841-1845.
18. Laghrissi-Thode, F., Wagner, W. R., Pollock, B. G., et al (1997) Elevated platelet factor 4 and b-thromboglobulin plasma levels in depressed patients with ischaemic heart disease. Biological Psychiatry, 42, 290-295.
19. Mansour, V. M., Wilkinson, D. J. C., Jennings, G. L., et al (1998) Panic disorder: coronary spasm as a basis for cardiac risk? Medical Journal of Australia, 168, 390-392.
20. Merikangas, K. R. & Merikangas, J. R. (1995) Combination mono-amine oxidase inhibitor and b-blocker treatment of migraine, with anxiety and depression. Biological Psychiatry, 38, 603-610.
21. Musselman, D. L., Marzec, U. M., Manatunga, A., et al (2000) Platelet reactivity in depressed patients treated with paroxetine. Archives of General Psychiatry, 57, 875-882.
22. Psychopharmacological Drugs Advisory Committee (2000) FDA Background on Zeldox™ (ziprasidone hydrochloride capsules). Washington, DC: Federal Drugs Administration. http://www.fda.gov/ohrms/dockets/ac/00/backgrd/3619b1b.pdf
23. Penninx, B. W. J. H., Beekman, A. T. F., Honig, A., et al (2001) Depression and cardiac mortality. Archives of General Psychiatry, 58, 221-227.
24. Reilly, J. G., Ayis, S. A., Jones, S. J., et al (2000) QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet, 355, 1048-1052.
25. Roose, S. P., Glassman, A. H., Giardina, E. G. V., et al (1987) Tricyclic antidepressants in depressed patients with cardiac conduction disease. Archives of General Psychiatry, 44, 273-275.
26. Roose, S. P., Glassman, A. H., Attia, E. et al (1998a) Cardiovascular effects of fluoxetine in depressed patients with heart disease. American Journal of Psychiatry, 155, 660-665.
27. Roose, S. P., Laghrissi-Thode, F., Kennedy, J. S., et al (1998b) Comparison of paroxetine and nortriptyline in depressed patients with ischaemic heart disease. Journal of the American Medical Association, 279, 287-291.
28. Royal College of Psychiatrists (1997) The Association between Antipsychotic Drugs and Sudden Death (Council Report CR57). London: Royal College of Psychiatrists.
29. Silver, H., Kogan, H. & Zlotogorski, D. (1990) Postural hypotension in chronically medicated schizophrenics. Journal of Clinical Psychiatry, 51, 459-462.
30. Tamargo, J. (2000) Drug-induced torsade de pointes: from molecular biology to bedside. Japanese Journal of Pharmacology, 83, 1-19.
31. Tie, H., Walker, B. D., Valenzuela, S. M, et al (2000) The heart of psychotropic drug therapy. Lancet, 395, 1825.
32. Tie, H., Walker, B. D., Singleton, C. B., et al (2001) Clozapine and sudden death. Journal of Clinical Psychopharmacology, 21, 630-632.
33. Waddington, J. L., Youssef, H. A. & Kinsella, A. (1998) Mortality in schizophrenia. Antipsychotic polypharmacy and absence of adjunctive anticholinergics over the course of a 10-year prospective study. British Journal of Psychiatry, 173, 325-329.
34. Warrington, S. J., Padgham, C. & Lader, M. (1989) The cardiovascular effects of antidepressants. Psychological Medicine, Monograph Supplement, 16, 1-40.
35. Wendkos, M. H. (1967) Cardiac changes related to phenothiazine, with special reference to thioridazine. Journal of the American Geriatrics Society, 15, 20-28.